Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
brain tumor
Biotech
Merck snaps up preclinical DNA biotech for $1.3B biobucks
The Big Pharma is spending $30 million to buy Modifi Biosciences while also putting $1.3 billion on the line if certain milestones are met.
Darren Incorvaia
Oct 23, 2024 7:05am
DeepGlioma AI classifies brain tumors within 90 seconds: study
Mar 27, 2023 8:15am
Servier’s $1.8B bet on Agios delivers phase 3 brain tumor win
Mar 14, 2023 10:15am
Good day for Day One as pediatric brain tumor drug proves worth
Jan 9, 2023 11:43am
Day One spends day 2 hitting up public markets for $150M
Jun 15, 2022 11:16am
How a vitamin might help fight glioblastoma
Apr 1, 2020 2:00pm
